RxDoctor Payments Data

Emily Greaves

Nurse Practitioner · Naperville, ILNPI 1114707007

Payments from drug & device makers

$1,017in general payments, 2019–2025

Across 33 payments — averaging $30.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kestra Medical Technology Services, Inc.$173
  • Boston Scientific$143
  • Boehringer Ingelheim$134
  • AstraZeneca$118
  • Abiomed$106
  • Heartflow, Inc.$74
  • plus $268 from 9 others

What the payments were for

  • Food & beverage$1,017100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,017 in reported general payments places this provider in the 80th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$54,309
Medicare patients
391
Services billed
1,052

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban85$91,094
XareltoRivaroxaban19$26,468
JardianceEmpagliflozin15$19,837
EntrestoSacubitril/Valsartan18$19,239
Metoprolol Succinate164$2,275
Midodrine Hcl40$1,656
Rosuvastatin Calcium71$910
Atorvastatin Calcium97$812
Amlodipine Besylate86$682
Torsemide29$679
Carvedilol67$616
Furosemide116$538
Spironolactone52$485
Hydralazine Hcl42$419
ClopidogrelClopidogrel Bisulfate38$371

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$28$91,09485 claims
Johnson & JohnsonXarelto$31$26,46819 claims
Boehringer IngelheimJardiance$134$19,83715 claims
NovartisEntresto$25$19,23918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Naperville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →